Skip Navigation

Continuing Education in Anaesthesia, Critical Care & Pain 2004 4(5):164-168; doi:10.1093/bjaceaccp/mkh045
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nair, V P.
Right arrow Articles by Hunter, J. M
Right arrow Search for Related Content
PubMed
Right arrow Articles by Nair, V P.
Right arrow Articles by Hunter, J. M
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Continuing Education in Anaesthesia, Critical Care & Pain | Volume 4 Number 5 2004 © The Board of Management and Trustees of the British Journal of Anaesthesia 2004

Anticholinesterases and anticholinergic drugs

V Priya Nair, MB BS FRCA, Honorary Lecturer
University Department of Anaesthesia, University Clinical Department, Duncan Building, Daulby Street, Liverpool, L69 3GA

Jennifer M Hunter, MB CHB PHD FRCA, Professor of Anaesthesia
University Department of Anaesthesia, University Clinical Department, Duncan Building, Daulby Street, Liverpool, L69 3GA
Tel: 01517 064008, Fax: 01517 065884, E-mail: jennie{at}liv.ac.uk (for correspondence)

Non-depolarizing neuromuscular block is monitored throughout surgery and antagonized at the end of anaesthesia to restore muscle tone rapidly and completely, so that patients can maintain a patent airway and adequate pulmonary ventilation. Rapid, reliable antagonism of competitive neuromuscular block only occurs if spontaneous recovery from block has commenced before antagonism. The agents commonly used to effect it are the anticholinesterases. By their inhibitory effect on the enzyme acetylcholinesterase, these drugs increase the amount of acetylcholine at the neuromuscular junction, thus overcoming the effects of any residual neuromuscular blocking agent.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.